News

Sector Rotation And 9 Stocks To Watch During A Recession

  • Is the United States heading toward a recession? This has been the looming question on the minds of Americans since inflation topped at 8.5% in March, matched with other indicators such as rising interest rates and the bond market's inverted yield curve.
    05/18/2022

Regencell Bioscience's COVID-19 Candidate Shows Encouraging Action On Mild To Moderate Symptoms

  • Regencell Bioscience Holdings Limited (NASDAQ: RGC) announced the results from the EARTH efficacy trial of its COVID-19 candidate. RGC-COV19 (Regencell Bioscience (RGCA-CV01) liquid formulation) is an oral TCM candidate.
    02/17/2022
Profitability
Dividends
Income Statement
Balance Sheet
Cash Flow Statement
Symbol Frequently Asked Questions

Regencell Bioscience Holdings Limited (RGC) can hold. Click on Rating Page for detail.

The price of Regencell Bioscience Holdings Limited (RGC) is 5.22 and it was updated on 2024-04-18 13:00:35.

Currently Regencell Bioscience Holdings Limited (RGC) is in undervalued.

News
    
News

Regencell Bioscience Stock Jumps On Formation Of COVID-19 Treatment Focused Joint Venture

  • Regencell Bioscience Holdings Ltd's (NASDAQ: RGC) subsidiary in Hong Kong has entered into a joint venture agreement with Honor Epic Enterprises Limited to offer COVID-19 related treatments. The joint venture will cater to patients in ASEAN countries, India, Japan, Australia, and New Zealand.
    Thu, Sep. 02, 2021

RGC Stock: Over 40% Pre-Market Details

  • The stock price of Regencell Bioscience Holdings Ltd (NASDAQ: RGC) increased by over 40% pre-market. This is why it happened.
    Wed, Aug. 25, 2021

Regencell Bioscience Shares Increased 204.13%: Why It Happened

  • The shares of Regencell Bioscience Holdings Ltd (NASDAQ: RGC) increased 204.13% in the previous trading session on August 20. This is why it happened.
    Sun, Aug. 22, 2021

Is RGC Stock Rallying On Mistaken Identity?

  • Will RGC Stock Crash Or Go Higher After Today? The post Is RGC Stock Rallying On Mistaken Identity?
    Fri, Aug. 20, 2021

Regencell Bioscience Holdings Limited Announces Partial Exercise of Underwriter's Over-Allotment Option

  • HONG KONG--(BUSINESS WIRE)--Regencell Bioscience Holdings Limited (NASDAQ:RGC) ("Regencell" or the "Company"), an early-stage bioscience company that focuses on research, development and commercialization of Traditional Chinese Medicine ("TCM") for the treatment of neurocognitive disorders and degeneration, specifically Attention Deficit Hyperactivity Disorder ("ADHD") and Autism Spectrum Disorder ("ASD"), today announced that the underwriter of its initial public offering (the “Offering”) had
    Fri, Aug. 20, 2021
SEC Filings
SEC Filings
Press Releases
StockPrice Release
More Headlines
News

7 Companies Begin Trading. Here's How They're Doing.

  • The group is diverse—a fintech, three biotechs, a real-estate investment manager, a bioscience company, and a pharmaceutical glassmaker.
  • 07/16/2021
Unlock
RGC Ratings Summary
RGC Quant Ranking